2021 Prediction – What The Year Holds For Medicinal Cannabis Industry In New ZealandPosted by On


World vs New Zealand

New Zealand’s nascent
Medicinal Cannabis industry in 2021 will hugely be
influenced by the comparable legalised world territories. At
current global industry predictions, if it keeps growing at
600 to 700 per cent, it is going to be enormous in next four
to five years. Another tantalising prospect appeared on the
horizon is that President Joe Biden’s administration may end
the US federal prohibition that will have a cascading effect
down under. Further, the move by the UN in December 2020 by
removing Cannabis from the list of world’s most dangerous
drugs into medicinal drug can be in New Zealand favour. This
phytochemical industry expansion opportunity on orphan plant
can trigger innovative research to create unique
pharmaceutical products with New Zealand’s clean green
image.

Regulations and compliance

New Zealand
should learn from Australia rather than reinventing the
wheel in 2021! Australian product development from their
local cultivation has mostly initiated in 2020 which will
squeeze the cheap imports from the Americas to Australia and
eventually to New Zealand. New Zealand should follow and
fast track its learning from the Australian market unique
product development and clinical trials models, as we…

Original Author Link click here to read complete story..

World vs New Zealand

New Zealand’s nascent
Medicinal Cannabis industry in 2021 will hugely be
influenced by the comparable legalised world territories. At
current global industry predictions, if it keeps growing at
600 to 700 per cent, it is going to be enormous in next four
to five years. Another tantalising prospect appeared on the
horizon is that President Joe Biden’s administration may end
the US federal prohibition that will have a cascading effect
down under. Further, the move by the UN in December 2020 by
removing Cannabis from the list of world’s most dangerous
drugs into medicinal drug can be in New Zealand favour. This
phytochemical industry expansion opportunity on orphan plant
can trigger innovative research to create unique
pharmaceutical products with New Zealand’s clean green
image.

Regulations and compliance

New Zealand
should learn from Australia rather than reinventing the
wheel in 2021! Australian product development from their
local cultivation has mostly initiated in 2020 which will
squeeze the cheap imports from the Americas to Australia and
eventually to New Zealand. New Zealand should follow and
fast track its learning from the Australian market unique
product development and clinical trials models, as we…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.